In just one week, nearly 7,000 individuals have used the tracker to report that they cannot access their medications, with brand name products containing semaglutide reported as being the most challenging to access
Funding: This work was supported by grants from the Science and Technology Innovation 2030-Major Project of the Ministry of Science and Technology of China, the National Natural Science Foundation of Distinguished Young Scholars, the National Natural Science Foundation of China, the Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China, the Major Science and Technology Projects in Jiangsu Province, the Natural Science Foundation Outstanding Youth Fund of Jiangsu Province, the Fundamental Research Funds for the Central Universities, the Jiangsu Province High-Level Hospital Construction Funds of Zhongda Hospital, School of Medicine, Southeast University, and the Nanjing U35 Strong Foundation Program
Studies have demonstrated that GLP-1 medications have the potential to lead to significant weight loss in individuals with obesity or overweight
Some of the common side effects reported with the use of GLP-1 analogues include: Precautions and Interactions: While GLP-1 analogues have shown significant promise in improving health outcomes, certain precautions should be considered before starting treatment
Hu Y, Liu J, Wang G, Xu Y